INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,367,000 | +40.6% | 732,669 | -7.8% | 0.01% | +28.6% |
| Q4 2020 | $1,684,000 | +122.2% | 794,586 | +22.7% | 0.01% | +133.3% |
| Q3 2020 | $758,000 | +40.6% | 647,394 | +8.6% | 0.00% | +50.0% |
| Q2 2020 | $539,000 | +9.3% | 595,912 | +1.2% | 0.00% | -33.3% |
| Q1 2020 | $493,000 | -19.0% | 588,874 | -7.1% | 0.00% | 0.0% |
| Q4 2019 | $609,000 | -4.8% | 633,610 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $640,000 | -40.9% | 620,845 | +3.2% | 0.00% | -40.0% |
| Q2 2019 | $1,083,000 | +6.2% | 601,517 | +10.9% | 0.01% | +25.0% |
| Q1 2019 | $1,020,000 | +79.3% | 542,519 | +12.5% | 0.00% | +33.3% |
| Q4 2018 | $569,000 | -40.8% | 482,136 | +36.0% | 0.00% | -25.0% |
| Q3 2018 | $961,000 | +35.2% | 354,466 | -4.7% | 0.00% | +33.3% |
| Q2 2018 | $711,000 | +77.8% | 372,009 | +95.2% | 0.00% | +50.0% |
| Q1 2018 | $400,000 | +506.1% | 190,573 | +485.2% | 0.00% | – |
| Q4 2017 | $66,000 | +34.7% | 32,566 | -11.9% | 0.00% | – |
| Q3 2017 | $49,000 | -83.7% | 36,984 | -80.8% | 0.00% | -100.0% |
| Q2 2017 | $301,000 | -84.1% | 192,276 | -67.1% | 0.00% | -88.9% |
| Q1 2017 | $1,888,000 | +1769.3% | 585,232 | +689.0% | 0.01% | – |
| Q4 2016 | $101,000 | -52.6% | 74,175 | -45.9% | 0.00% | -100.0% |
| Q3 2016 | $213,000 | -52.2% | 137,093 | -59.1% | 0.00% | -50.0% |
| Q2 2016 | $446,000 | -72.9% | 335,203 | +7.6% | 0.00% | -75.0% |
| Q1 2016 | $1,643,000 | -64.1% | 311,639 | -46.5% | 0.01% | -66.7% |
| Q4 2015 | $4,571,000 | -47.6% | 582,278 | -43.6% | 0.02% | -50.0% |
| Q3 2015 | $8,718,000 | -36.4% | 1,031,894 | -17.5% | 0.05% | -27.3% |
| Q2 2015 | $13,705,000 | +26.4% | 1,251,479 | +61.3% | 0.07% | +32.0% |
| Q1 2015 | $10,844,000 | +195.7% | 775,732 | +257.5% | 0.05% | +212.5% |
| Q4 2014 | $3,667,000 | – | 217,014 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |